Search

Limited research has been conducted to explore the racial trauma experience of East Asian American women, especially in the workplace. We sought to understand (a) how racial trauma has influenced this population's work and non-work life and (b) how they have coped with this traumatic stress in career development and mental health aspects. Twelve participants working in the United States participated in semi-structured interviews about the impact of workplace racial trauma on their mental health, work, relationships, and coping strategies. Five domains were developed using conventional content analysis: (a) racial trauma at work is expressed with microaggression, (b) racial trauma causes a loss of psychological safety, (c) racial trauma creates relationship dilemmas, (d) racial trauma creates challenges in participants' career development paths, and (e) career and mental health coping strategies are used to manage racial traumatic stress. Implications for theoretical advances and counseling and organizational practice are also discussed.

In situ vaccination (ISV) triggers antitumor immune responses using the patient's own cancer antigens, yet limited neoantigen release hampers its efficacy. Our novel combination therapy involves low-dose local cisplatin followed by ISV with a TLR7/8/9 agonist formulation (CR108), in which CR108 boosts and sustains the antitumor responses induced by the cisplatin-released neoantigens. In mouse models, the cisplatin+CR108 combination significantly outperformed cisplatin or CR108 alone in abrogating established 4T1 and B16 tumors. The synergistic antitumor effects of cisplatin and CR108 were accompanied by markedly increased tumor tertiary lymphatic structures (TLS) formation, higher levels of type I and III interferons and TNF-α in serum, augmented T and B lymphocyte infiltration, antigen-presenting cell activation, as well as reduced functionally of exhausted T cells. Single-cell sequencing analysis uncovered a potential pathway for TLS to serve as a reservoir for functional antitumor effector T cells. Furthermore, cisplatin+CR108 combo therapy, but neither cisplatin nor CR108 alone, effectively inhibited the growth of treated 4T-1 tumor in an effector T cell-dependent manner. Notably, the combo therapy also suppressed the growth of distant untreated 4T-1 tumors, demonstrating systemic antitumor effects. Moreover, combo-therapy led to full regression of 4T-1 tumors in a large percentage of mice, who became strongly resistant to secondary tumor challenge, a clear indication of antitumor immunological memory. The cisplatin+CR108 combo therapy holds promise in converting "cold" tumors into "hot" ones and eliciting robust antitumor immune responses in vivo. [ABSTRACT FROM AUTHOR]

Flexible luminescent materials are usually in the form of gels and films. Solid‐state films have advantages in practical applications due to their long‐term stability. However, the fabrication process by conventional methods remains laborious and unsustainable. Here, a facile and green route is reported for fabricating flexible luminescent films via an elegant solid‐phase molecular self‐assembly design. First, Eu3+/Tb3+‐based metallosupramolecular coordination polyelectrolytes (MEPEs) and tetraphenylethylene (TPE)‐based MEPEs are designed with an antenna bis‐ligands to get individual R, G, and B emission. Then, by repeatedly pressing the MEPEs‐cetyltrimethylammonium bromide (CTAB) precipitates, obtained from their mixing aqueous solutions, R, G, and B emission films are obtained at room temperature, respectively. The emission color can be simply tuned by adjusting molar ratio of Eu3+: Tb3+: TPE. Notably, humidity‐responsive white emission film is obtained when Eu3+: Tb3+: TPE = 3:1:2.5. Owing to the dynamic coordination and electrostatic interaction, which can be activated by hydrating water, these films can be facilely reprocessed and self‐healed with the aid of water at room temperature. It is hoped that this approach to fabricate flexible supramolecular luminescent films can be applied to design various advanced functional soft materials. [ABSTRACT FROM AUTHOR]

To create tissue-engineered vascular grafts (TEVGs) in vitro, vascular smooth muscle cells (VSMCs) must function effectively and produce sufficient extracellular matrix (ECM) in a three-dimensional space. In this study, we investigated whether the addition of insulin-transferrin-selenium (ITS), a medium supplement, could enhance TEVG formation. PGA fabric was used as the scaffold, and 1% ITS was added to the medium. After two weeks, the tissues were examined using electron microscopy and staining. The ITS group exhibited a denser structure and increased collagen production. VSMCs were cultured in two dimensions with ITS and assessed for collagen production, cell growth, and glucose metabolism. The results showed that ITS supplementation increased collagen production, cell growth, glucose utilization, lactate production, and ATP levels. Furthermore, reducing the amount of fetal bovine serum (FBS) in the medium did not affect the TEVGs or VSMCs when ITS was present. In conclusion, ITS improves TEVG construction by promoting VSMCs growth and reducing the need for FBS. [ABSTRACT FROM AUTHOR]